WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--MED Institute, a leader in pre-clinical and clinical medical product development services, is proud to announce a strategic collaboration with Sus Clinicals, a ...

Welcome to Med Op-Ed, where we highlight recently published editorials. In this installment: Direct-to-consumer sexually transmitted infection (STI) testing may lead to gaps in public health; ...

President Donald Trump on Thursday vowed to begin testing US nuclear weapons “on an equal basis” with Russia and China, heralding a potentially major shift in decades of US policy at a time of growing ...

EAST GREENBUSH, N.Y. (NEWS10) — An East Greenbush woman said a simple medical test helped save her life. Now she and her doctor want to share a critical message about heart health. “I was somebody who ...

Measuring elevated levels of insulin in the blood, called hyperinsulinemia, is a proven way to measure metabolic health and can show the risk of developing future health concerns, including type 2 ...

The FDA has cleared its first completely at-home sexual health test for women, available over-the-counter to screen for chlamydia, gonorrhea and trichomoniasis. The single-use kit from Visby Medical ...

Hydrogen and methane breath tests (HMBT) are a noninvasive diagnostic tool commonly employed to evaluate small intestinal bacterial overgrowth (SIBO) and issues with carbohydrate malabsorption, such ...

Americans can no longer order free at-home COVID-19 tests from the government through COVIDtests.gov. The suspension of the program, which has distributed over 1.8 billion COVID tests across the ...

TOLEDO, Ohio, March 3, 2025 /PRNewswire/ -- NAMSA, a leading US based MedTech testing, clinical and regulatory consulting firm, announced that it finalized its acquisition of WuXi AppTec’s US medical ...

Quest Diagnostics will take over the kidney-focused lab testing portfolio of the dialysis giant Fresenius Medical Care—including services that Quest will then provide back to Fresenius as well as its ...

This analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory ...